SEPN
Septerna, Inc.Company with tickers: SEPN
CIK
1984086
CUSIP
81734D104
Shares Outstanding
44,906,374
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-15 | Bhatt Elizabeth | President and COO | Convert | 4,000 |
| 2026-04-15 | Bhatt Elizabeth | President and COO | Convert | 4,000 |
| 2026-04-15 | Bhatt Elizabeth | President and COO | Sell | 2,573 |
| 2026-03-02 | Shaikhly Samira | Chief People Officer | Sell | 4,090 |
| 2026-03-02 | Shaikhly Samira | Chief People Officer | Convert | 53,714 |
| 2026-03-02 | Shaikhly Samira | Chief People Officer | Convert | 53,714 |
| 2026-02-18 | Bhatt Elizabeth | President and COO | Sell | 2,200 |
| 2026-02-18 | Bhatt Elizabeth | President and COO | Convert | 4,000 |
| 2026-02-18 | Bhatt Elizabeth | President and COO | Convert | 4,000 |
| 2026-02-06 | Klein Uwe | SVP, Biological Sciences | Award | 80,000 |
| 2026-02-06 | Wilson Mark Andrew | Chief Legal Officer | Award | 165,000 |
| 2026-02-06 | Long Daniel D. | SVP, Drug Discovery | Award | 80,000 |
| 2026-02-06 | Shaikhly Samira | Chief People Officer | Award | 80,000 |
| 2026-02-06 | Labrucherie Gil M | SVP, COO & CFO | Award | 125,000 |
| 2026-02-06 | Kim Jae B. | Chief Medical Officer | Award | 125,000 |
| 2026-02-06 | Bhatt Elizabeth | President and COO | Award | 155,000 |
| 2026-02-06 | Finer Jeffrey | Director, Chief Executive Officer | Award | 400,000 |
| 2026-01-05 | Wilson Mark Andrew | Chief Legal Officer | Other | 0 |
| 2025-11-10 | Long Daniel D. | SVP, Drug Discovery | Sell | 3,501 |
| 2025-09-25 | Gottesdiener Keith Michael | Director, See Remarks | Award | 33,246 |
| 2025-09-25 | Gottesdiener Keith Michael | Director, See Remarks | Other | 0 |
| 2025-08-18 | Klein Uwe | SVP, Biological Sciences | Convert | 10,452 |
| 2025-08-18 | Klein Uwe | SVP, Biological Sciences | Other | 104,525 |
| 2025-08-18 | Klein Uwe | SVP, Biological Sciences | Convert | 10,452 |
| 2025-08-07 | Kim Jae B. | Chief Medical Officer | Award | 55,000 |
| 2025-08-07 | Labrucherie Gil M | SVP, COO & CFO | Award | 37,500 |
| 2025-08-07 | Finer Jeffrey | Director, Chief Executive Officer | Award | 210,000 |
| 2025-08-07 | Shaikhly Samira | Chief People Officer | Award | 30,000 |
| 2025-08-07 | Bhatt Elizabeth | President and COO | Award | 95,000 |
| 2025-08-07 | Long Daniel D. | SVP, Drug Discovery | Award | 30,000 |
| 2025-08-07 | Klein Uwe | SVP, Biological Sciences | Award | 30,000 |
| 2025-06-17 | Tong Jeffrey K | Director | Award | 16,623 |
| 2025-06-17 | Coulie Bernard | Director, President and CEO | Award | 16,623 |
| 2025-06-17 | Simson Jake | Director | Award | 16,623 |
| 2025-06-17 | Bassan Abraham | Director | Award | 16,623 |
| 2025-06-17 | Ezekowitz Alan | Director | Award | 16,623 |
| 2025-06-17 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 16,623 |
| 2025-06-17 | Sharp Shalini | Director | Award | 16,623 |
| 2025-04-03 | Finer Jeffrey | Director, Chief Executive Officer | Convert | 5,000 |
| 2025-04-03 | Finer Jeffrey | Director, Chief Executive Officer | Convert | 5,000 |
| 2025-04-02 | Finer Jeffrey | Director, Chief Executive Officer | Convert | 50,000 |
| 2025-04-02 | Finer Jeffrey | Director, Chief Executive Officer | Convert | 50,000 |
| 2025-03-07 | Ezekowitz Alan | Director | Buy | 13,319 |
| 2025-03-06 | Ezekowitz Alan | Director | Buy | 41,355 |
| 2025-03-05 | Ezekowitz Alan | Director | Buy | 37,835 |
| 2025-03-04 | Ezekowitz Alan | Director | Buy | 7,491 |
| 2025-02-27 | Finer Jeffrey | Director, Chief Executive Officer | Buy | 3,000 |
| 2025-02-27 | Labrucherie Gil M | SVP, COO & CFO | Buy | 3,718 |
| 2025-02-26 | Finer Jeffrey | Director, Chief Executive Officer | Buy | 4,000 |
| 2025-02-25 | Finer Jeffrey | Director, Chief Executive Officer | Buy | 10,000 |
| 2025-02-25 | Labrucherie Gil M | SVP, COO & CFO | Buy | 6,282 |
| 2025-02-24 | Third Rock Ventures VI, L.P. | Director | Other | 6,215,591 |
| 2025-02-24 | Third Rock Ventures VI, L.P. | Director | Buy | 18,861 |
| 2025-02-21 | Labrucherie Gil M | SVP, COO & CFO | Buy | 5,000 |
| 2025-02-21 | Third Rock Ventures VI, L.P. | Director | Buy | 427,668 |
| 2025-02-20 | Labrucherie Gil M | SVP, COO & CFO | Buy | 14,500 |
| 2025-02-20 | Third Rock Ventures VI, L.P. | Director | Buy | 612,674 |
| 2025-02-20 | Third Rock Ventures VI, L.P. | Director | Other | 6,215,591 |
| 2025-02-19 | Labrucherie Gil M | SVP, COO & CFO | Buy | 10,500 |
| 2025-02-07 | Labrucherie Gil M | SVP, COO & CFO | Award | 222,000 |
| 2025-01-06 | Labrucherie Gil M | SVP, COO & CFO | Other | 0 |
| 2024-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 3,828,400 |
| 2024-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 14,598,896 |
| 2024-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 1,695,515 |
| 2024-10-28 | Third Rock Ventures V, L.P. | 10% Owner | Other | 24,737,017 |
| 2024-10-28 | Third Rock Ventures V, L.P. | 10% Owner | Other | 4,790,773 |
| 2024-10-28 | Third Rock Ventures V, L.P. | 10% Owner | Other | 41,250,000 |
| 2024-10-28 | Third Rock Ventures V, L.P. | 10% Owner | Buy | 370,500 |
| 2024-10-24 | Klein Uwe | SVP, Biological Sciences | Other | 104,525 |
| 2024-10-24 | Klein Uwe | SVP, Biological Sciences | Other | 0 |
| 2024-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 0 |
| 2024-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 0 |
| 2024-10-24 | Xiao Ran | Interim CFO | Other | 0 |
| 2024-10-24 | Xiao Ran | Interim CFO | Other | 58,069 |
| 2024-10-24 | Kim Jae B. | Chief Medical Officer | Other | 0 |
| 2024-10-24 | Third Rock Ventures V, L.P. | 10% Owner | Other | 1,054,318 |
| 2024-10-24 | Third Rock Ventures V, L.P. | 10% Owner | Other | 0 |
| 2024-10-24 | Third Rock Ventures V, L.P. | 10% Owner | Other | 0 |
| 2024-10-24 | Simson Jake | Director | Other | 0 |
| 2024-10-24 | Bhatt Elizabeth | President and COO | Other | 174,209 |
| 2024-10-24 | Bhatt Elizabeth | President and COO | Other | 0 |
| 2024-10-24 | Tong Jeffrey K | Director | Other | 0 |
| 2024-10-24 | Shaikhly Samira | Chief People Officer | Other | 0 |
| 2024-10-24 | Finer Jeffrey | Director, Chief Executive Officer | Other | 0 |
| 2024-10-24 | Finer Jeffrey | Director, Chief Executive Officer | Other | 754,907 |
| 2024-10-24 | Ezekowitz Alan | Director | Other | 17,420 |
| 2024-10-24 | Ezekowitz Alan | Director | Other | 0 |
| 2024-10-24 | Sharp Shalini | Director | Other | 0 |
| 2024-10-24 | Coulie Bernard | Director, President and CEO | Other | 0 |
| 2024-10-24 | Bassan Abraham | Director | Other | 0 |
| 2024-10-24 | Long Daniel D. | SVP, Drug Discovery | Other | 92,911 |
| 2024-10-24 | Long Daniel D. | SVP, Drug Discovery | Other | 0 |